Interactive Mobile Health Information to Enhance Patient Care at a Cystic Fibrosis Center
Completed · Not applicable
Conditions studied: Medication Adherence, Cystic Fibrosis
In brief
Real-world adherence to inhaled and oral therapies for cystic fibrosis (CF) patients remains discouragingly low, ranging between 31-53% for inhaled antibiotics and 41-72% for hypertonic saline. Programs to enhance adherence, including comprehensive behavioral interventions with adolescents, have met with mixed success. Advances in therapy, treatment delivery systems, and data capture technology offer the potential for enhancing adherence by providing immediate and more frequent feedback to the patient regarding his or her fidelity to the prescribed treatment regimen. The investigators propose to evaluate a systematic yet technically simple approach to linking treatment and feedback components to enhance adherence in a real-work CF clinic setting that treats a significant minority patient population. This is the first trial assessing the impact of a collaborative active intervention program of a multi disciplinary team in improving adherence to specific chronic medications and improving clinical outcomes in CF patients. The PI has implemented the texting service (Caremessage.org) with COPD and diabetes patients. The content will be modified to provide both English and Spanish language content relevant to these participants and their standard treatment protocols.
Key facts
- Study ID
- NCT03052231
- Run by
- Landon Pediatric Foundation
- People needed
- 80
- Starts
- 2016-03-01
- Expected to finish
- 2017-02-01
- Last updated by the study team
- 2019-05-07
Who can join
Age: 4 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patients with diagnosis of Cystic fibrosis at all ages;
- Their associated CF Center professionals;
- Their associated family;
- CF patients that should be treated with one or more of these chronic medications: Tobi (Tobramycin), (Colistin), Pulmozyme (Dornase Alpha), Hypertonic Saline (HS), Creon (pancreatic enzymes), AquaADEKs (Multivitamin);
- Patients willing to participate in a trial;
- Presence of a parent/guardian capable of providing informed consent; and
- Patients attending CF clinic at least once every 12 months.
You may not qualify if…
- Absence of a parent/guardian or unwillingness to provide permission;
- Potential participant declines to provide assent; and
- Transplant patients.
Where it is running
- Pediatric Diagnostic Center — Ventura, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.